D
Sell
9/1/2023Upgraded
Coya Therapeutics, Inc. (COYA) was upgraded to D- from E on 09/01/2023.
E
Sell
8/10/2023Downgrade
Coya Therapeutics, Inc. (COYA) was downgraded to E from E+ on 8/10/2023 due to a noticeable decline in the volatility index, efficiency index and total return index. Total capital declined 17.98% from $16.15M to $13.25M, and net income declined 13.12% from -$2.74M to -$3.1M.
E
Sell
6/2/2023Upgraded
Coya Therapeutics, Inc. (COYA) was upgraded to E+ from E on 6/2/2023 due to a significant increase in the solvency index, volatility index and growth index. The quick ratio increased from 1.55 to 12.89, and earnings per share increased from -$1.1998 to -$0.2815.
E
Sell
4/21/2023Upgraded
Coya Therapeutics, Inc. (COYA) was upgraded to E from E- on 4/21/2023 due to an increase in the volatility index.
E
Sell
4/5/2023Downgrade
Coya Therapeutics, Inc. (COYA) was downgraded to E- from E on 4/5/2023 due to a decline in the growth index, volatility index and efficiency index. Operating cash flow declined 39.69% from -$1.59M to -$2.22M, and total capital declined 29.53% from $6.49M to $4.57M.
E
Sell
3/29/2023Upgraded
Coya Therapeutics, Inc. (COYA) was upgraded to E from E- on 3/29/2023 due to an increase in the total return index and volatility index.
E
Sell
3/27/2023None
Coya Therapeutics, Inc. (COYA) was downgraded to E- from U on 03/27/2023.
